S Eckert

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. ncbi Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
    B Ettinger
    Division of Research, Kaiser Permanente, Oakland, Calif 94611 5400, USA
    JAMA 282:637-45. 1999
  2. ncbi Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy
    B Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, CA, USA
    Am J Manag Care 5:779-85. 1999
  3. ncbi Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs
    B Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, 3505 Broadway, 7th Floor, Oakland, CA 94611 5714, USA
    Am J Manag Care 7:597-605. 2001
  4. ncbi Low-dosage esterified estrogens opposed by progestin at 6-month intervals
    B Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, California 94611 5463, USA
    Obstet Gynecol 98:205-11. 2001
  5. ncbi Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy
    Bruce Ettinger
    Division of Research, Kaiser Permanente Northern California, Oakland, Oakland, California 94611 5714, USA
    Obstet Gynecol 102:1225-32. 2003
  6. ncbi Limb fractures in elderly men as indicators of subsequent fracture risk
    Bruce Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, Calif 94611, USA
    Arch Intern Med 163:2741-7. 2003

Detail Information

Publications6

  1. ncbi Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
    B Ettinger
    Division of Research, Kaiser Permanente, Oakland, Calif 94611 5400, USA
    JAMA 282:637-45. 1999
    ..Raloxifene hydrochloride, a selective estrogen receptor modulator, prevents bone loss in postmenopausal women, but whether it reduces fracture risk in these women is not known...
  2. ncbi Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy
    B Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, CA, USA
    Am J Manag Care 5:779-85. 1999
    ..To determine possible differences in continuation of postmenopausal estrogen replacement therapy among women initiating treatment with transdermal estradiol versus those initiating treatment with oral estrogen...
  3. ncbi Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs
    B Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, 3505 Broadway, 7th Floor, Oakland, CA 94611 5714, USA
    Am J Manag Care 7:597-605. 2001
    ..To investigate use of osteoporosis drugs among patients with high exposure to glucocorticoid drugs...
  4. ncbi Low-dosage esterified estrogens opposed by progestin at 6-month intervals
    B Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, California 94611 5463, USA
    Obstet Gynecol 98:205-11. 2001
    ....
  5. ncbi Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy
    Bruce Ettinger
    Division of Research, Kaiser Permanente Northern California, Oakland, Oakland, California 94611 5714, USA
    Obstet Gynecol 102:1225-32. 2003
    ....
  6. ncbi Limb fractures in elderly men as indicators of subsequent fracture risk
    Bruce Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, Calif 94611, USA
    Arch Intern Med 163:2741-7. 2003
    ..Whether limb fracture in elderly men predicts future fracture is unknown...